Information technology governance practices and inhibitors in South African private and public health care

Author
John Mangundu

Synopsis

As organisations continue to invest capital heavily in Information Technology (IT), effective corporate governance of IT, normally termed 'IT governance' is critical to ensuring that IT spending leads to the fulfilment of organisational goals and the delivery of expected value. These changes in the business and IT operating environment require new and improved IT governance practices for implementation. The objective of this book is to determine IT governance drivers, IT governance practices and its inhibitors in private and public health care in South Africa. In this book, exploratory mixed methods with important IT and business decision-makers in the form of semi-structured interviews and an online survey questionnaires are used. The book makes original contributions to the IT governance and health care literature.

Chapters

  • Chapter 1
    Overview and background of the study
  • Chapter 2
    An integrated theory and series of propositions relating to governance and the branches of business governance, corporate governance and IT governance
  • Chapter 3
    Research philosophical grounding and assumptions
  • Chapter 4
    Materials and Methods
  • Chapter 5
    Presentation, interpretation, analysis of qualitative data from business and IT decision makers interviews relating to IT governance drivers, practices and inhibitors in South African private and public healthcare
  • Chapter 6
    Presentation, interpretation, analysis of quantitative data from business and IT decision makers interviews relating to IT governance drivers, practices and inhibitors in South African private and public healthcare
  • Chapter 7
    Integrated on IT governance drivers, practices and inhibitors in South African private and public health care
  • Chapter 8
    Conclusions and Recommendations

Downloads

Download data is not yet available.
Cover for Information technology governance practices and inhibitors in South African private and public health care